Time-to-event analysis shows faster pricing and reimbursement negotiations for new medicines after AIFA reform, indicating improved efficiency.
The consolidation of separate committees into a unified structure, as a part of the 2024 AIFA reform, was accompanied by accelerated P&R negotiations for new medicines in Italy, demonstrating that structural optimization of health technology assessment processes may enhance system efficiency.
No takes yet. Share an insight, caveat, or question.
Raspolini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: